TetraLogic Pharmaceuticals CorpGrey Market:TLOG
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0000
- Day Range
- 52 Week Range
- Volume40,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TLOG |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
TetraLogic Pharmaceuticals Corp | 20.0 | 0.0x | --- |
Verde Science Inc | 20.0 | 0.0x | --- |
Regnum Corp | 20.0 | 0.0x | --- |
OncoSec Medical Inc | 10.0 | 0.0x | --- |
Better Therapeutics Inc | 50.0 | 0.0x | --- |
Evolutionary Genomics Inc | 5.3K | 0.0x | --- |
Company Information
TetraLogic Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics in oncology, infectious diseases and autoimmune diseases. The Company's segment is the identification and development of novel small molecule therapies in oncology and infectious diseases. The Company has approximately two clinical-stage product candidates in development, such as birinapant and SHAPE. SHAPE is the Company's histone deacetylase (HDAC) inhibitor that it is developing for topical use for the treatment of early-stage cutaneous T-cell lymphoma (CTCL). The Company is also exploring studying SHAPE in alopecia areata, an autoimmune skin disease. SHAPE has been granted the United States orphan drug designation for CTCL. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases (SMAC)-mimetic, which leads to apoptosis or cell-death in damaged cells.
Contact Information
- Headquarters
- P.O. Box 1305MALVERN, PA, United States 19301
- Phone
- 610-889-9900
- Fax
- 610-889-9994
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $20.00 |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 24.8M |
TetraLogic Pharmaceuticals Corp does not pay a dividend. | |
Beta | 4.01 |
EPS | $-1.64 |
Book Value | $-0.24 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
